ImageneBio, Inc. (IMA)
Nasdaq: IMA · Biological Products, (No Diagnostic Substances) · San Diego, CA · filing with the SEC since 2021
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
| Report filed | Mar 10, 2026 | Mar 6, 2025 | Mar 12, 2024 | Mar 14, 2023 | Mar 17, 2022 | · |
| Revenue | 800 | 3,500 | 9,160 | 15,618 | 30,985 | 9,194 |
| For lenders | ||||||
| Interest expense on deposits and borrowings | 489 | 0 | · | · | · | · |
| Research and development | 28,525 | 32,109r | 59,652 | 64,321 | 47,108 | 44,847 |
| General and administrative | 20,726 | 8,391r | 24,925 | 22,201 | 18,015 | 8,866 |
| Total operating expenses | 49,251 | 40,500r | 84,577 | 86,522 | 65,123 | 53,713 |
| Operating income | -48,451 | -37,000r | -75,417 | -70,904 | -34,138 | -44,519 |
| Interest and investment income | · | 7,373 | 7,111 | 2,149 | 23 | · |
| Interest income (expense), net | 2,035 | 374 | · | · | · | · |
| Other income (expense), net | 717 | 71r | -22r | 2,139 | 23 | 263 |
| Total non-operating income (expense) | 2,752 | 445r | 7,089 | · | · | · |
| Income before income taxes | -45,699 | -36,555r | -68,328 | -68,765 | · | · |
| Income tax expense | -350 | 13r | -162 | 0 | 0 | · |
| Net income including non-controlling interests | -45,349 | -36,568r | -68,166 | -68,765 | -34,115 | -44,256 |
| Net income | -45,349 | -36,568r | -68,166 | -68,765 | -34,115 | -44,256 |
| Net income to common shareholders | -52,395 | -48,384 | · | · | · | · |
| Earnings per share, basic | -9.64 | -22.10r | -1.63 | -1.90 | -1.22 | · |
| Earnings per share, diluted | -9.64 | -22.10r | -1.63 | -1.90 | -1.22 | · |
| Earnings per share, basic and diluted | · | · | · | · | -1.22 | -16.00 |
| Weighted average shares, basic | 4,870,906 | 1,194,172r | 41,735,081 | 36,188,420 | 27,983,359 | · |
| Weighted average shares, diluted | · | 48,258,111 | 41,735,081 | 36,188,420 | 27,983,359 | · |
| Weighted average shares, basic and diluted | · | · | · | · | 27,983,359 | 2,765,494 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTaxInterest expense on deposits and borrowings what it paid for the money it lends
us-gaap:InterestExpenseOperatingResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeNet
us-gaap:InvestmentIncomeInterestInterest income (expense), net interest earned less interest paid, outside the business
us-gaap:InterestIncomeExpenseNonoperatingNetOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossNet income to common shareholders what is left for common shareholders
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasicEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted